Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin Regulation of Regional Adipose Tissue Lipolysis
NCT06175403Phase 1Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jan 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of niacin in obesity (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in plasma free fatty acid concentrations at 4 hours. Started Jan 2024; status: recruiting.
02
Drugs
niacin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06175403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06175403.